The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

Wegovy belongs to a pricey class of drugs called GLP-1s (short for glucagon-like peptide-1 agonists) that have upended the treatment of obesity in recent years, offering hope to patients who have ...